COMPOUNDS ACTING AT MULTIPLE PROSTAGLANDIN RECEPTORS GIVING A GENERAL ANTI-INFLAMMATORY RESPONSE
申请人:Allergan, Inc.
公开号:EP3424904A1
公开(公告)日:2019-01-09
The present invention provides a compound, that is a 1-(halo-2-[(2-hydrocarbyl or substituted hydrocarbyl)oxy]phenyl}methyl)-(fused bicyclic nitrogen heteroaryl) carboxylic acid or an ester or sulfonamide thereof. The compound may be represented by the following formula
Wherein R1, R2, R3, R4 A, X, W, Z and Y are as defined in the specification. The compounds may be administered to treat DP, FP, EP1, TP and/or EP4 receptor-mediated diseases or conditions.
本发明提供了一种化合物,它是 1-(卤代-2-[(2-氢羰基或取代羰基)氧基]苯基}甲基)-(融合双环氮杂芳基)羧酸或其酯或磺酰胺。该化合物可用下式表示
其中 R1、R2、R3、R4 A、X、W、Z 和 Y 如说明书中所定义。化合物可用于治疗 DP、FP、EP1、TP 和/或 EP4 受体介导的疾病或病症。